Carolyn Rodz joins the Houston Innovators Podcast this week. Photo courtesy of Hello Alice

Carolyn Rodz didn't feel the need to rush into Hello Alice's series B raise. The company, which was co-founded by Rodz and Elizabeth Gore in 2017, closed its series B at $21 million this summer, but Rodz says they did so with a specific goal.

Rodz, who joined the Houston Innovators Podcast this week, says she didn't want to get on the cycle that is round after round of venture capital. Instead, she's prioritizing profitability. And to have that, Hello Alice — platform for small business owners to find capital, networks and business services — needed to be able to reach more small business owners.

"When we made the decision to raise, it was really about making sure that we had good, strong core fundamentals and that we felt like we were putting good money to work where we can scale the business," Rodz says on the show. "It's our belief that the more smalls business owners we can support, it gives us a more unified and stronger voice to go implement systemic change."

The round was led by Virginia-based QED Investors with participation from new investors including Backstage Capital, Green Book Ventures, Harbert Growth Partners, and How Women Invest. It followed what was not only a rollercoaster of a year for the small businesses Hello Alice exists to serve, but also the company itself.

"It changed us permanently as a company," Rodz says of the pandemic.

On the show, Rodz characterizes the time for Hello Alice, which included slimming down the company's overhead, while simultaneously offering thought leadership, support, and resources for companies. Within a few days of the shutdown, Hello Alice was helping to deploy grants to entrepreneurs affected by COVID-19.

As challenging as the pandemic was for Hello Alice, it was validating too. Rodz says the company had a 700 percent increase in revenue and an 1,100 percent acquisition growth.

"We'd never operated in a downcycle, but what we learned through that process was that we're a really valuable resource for business owners when times are great, but we're also a really valuable resource for them when times are tough," she explains.

This validation set the scene for the series B, but following that raise, and, due in part to the doors opened by new investor networks, a new partnership with the NAACP Empowerment Program. Rodz says that the NAACP was given a lot of resources to put to work to build racial equity through economic empowerment. The relationship began with an introduction from Hello Alice investor, Green Book.

"They are real co-builders of this platform with us, so we're making sure we're actually putting money back into those communities," Rodz says of the partnerships Hello Alice has had with the NAACP and other equitable organizations. "NAACP was a huge milestone for us, something we're really proud of as a business. And I think it's a partnership that will continue to grow and make sure that we're aligned with how we're working on how we can build better together.

Rodz shares more on Hello Alice's growth as well as her observations on how Houston has evolved as an innovation ecosystem. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”